outcomes were mortality at 30 days and 6 months and
functional status (modified Rankin scale
99
) at discharge and
6 months (Table 3). At 6 months, recurrence occurred in 10 of
108 patients (9.3%) treated with a drain and 26 of 107 (24%)
without a drain (P = .003). There was lower mortality in the
drain group at both 30 days and at 6 months, although only at
6 months was the difference statistically significant (Table 3).
Patients left the hospital in better functional status if they were
treated with a drain, and this advantage was maintained at
6 months (Table 3). Medical and surgical complications were
much the same between the study groups. In accordance with
the previously published studies, the results of this trial
provide strong evidence for the use of drains with BHC.
Several groups have demonstrated benefit from intra-
operative irrigation.
100-103
Only Kuroki et al found . 6 times
higher recurrence (P = .49) in cases with (5 of 45, 11.1%) than
without (1 of 55, 1.8%) irrigation. Conversely, Aoki in a study
of TDC (without the use of postoperative drains) found
a lower recurrence rate in the cases when intraoperative
irrigation was used (1 of 15 versus 7 of 24; P = .096).
Collectively, these findings provide little support for the
hypothesis that a reduction in the concentration of profibri-
nolytic factors in the subdural fluid is the basis for the curative
effect of the drainage procedure (see above). It has to be
pointed out that none of the studies cited here were sufficiently
powered to demonstrate such a difference. In contrast, 2
studies in which postoperative continuous irrigation was used
showed that it is associated with a lower recurrence rate.
105,106
Most surgeons use 2 burr holes, mainly because doing
so allows better washout of the subdural cavity. Taussky
et al
107
have found higher recurrence rate if 1 rather than 2 burr
holes was used. In contrast, in the series by Han et al,
108
the
recurrence rate was 1 of 51 (2%) if 1 burr hole and 9 of
129 (7%) if 2 burr holes were used. This difference was not
statistically significant (P = .19). Both studies were retro-
spective series, and a number of factors, including the decision
making as to when 1 or 2 burr holes should be drilled, may
have been responsible for obtaining such disparate results. If
drains are used, it seems to be more advantageous to insert
them via frontal burr hole because this technique was found to
be associated with lower recurrence.
109,110
Craniotomy
Until the mid-1960s, craniotomy was the prevailing
technique used to evacuate CSDH.
111,112
In 1964, Svien and
Gelety
112
published a series of 69 patients with primary CSDH
TABLE 1. Presentation of Patients With Chronic Subdural Hematoma
Santarius et al
88
Mori and Maeda
86
Sambasivan
83
Krup and Jans
141
McKissock et al
142
Country
England
Japan
India
Germany
England
Year
2009
2001
1997
1995
1960
Average age
77
69
49
a
65
49
a
Series size
215
500
2300
212
216
Gait disturbance or falls
54
63
.
.
.
Mental deterioration
33
25
.
.
.
Limb weakness
33
59
.
45
22
Acute confusion
31
.
.
18
38
Headache
17
38
15
41
81
Drowsiness or coma
9
17
15
65
47
Speech impairment
6
2
.
18
6
Nonspecific deterioration
3
.
.
.
.
Collapse
1
.
.
.
.
Seizures
1
2
12
6
9
Incontinence
1
17
.
.
-
Visual disturbance
1
.
12
.
13
Vomiting
1
3
.
11
30
Vertigo
.
.
.
12
6
Strokelike symptoms
b
.
.
29
.
.
Behavioral disturbance
b
.
.
18
.
.
The series were selected arbitrarily to illustrate the presentation of patients with chronic subdural hematoma in different series. Only series with . 200 cases
and those with clinical presentations specifically listed were considered.
a
These series included pediatric cases.
b
Naming and classification of symptoms and signs differed between series. They were made to fit categories used in our recent publication.
88
Only when this
was not possible were the original categories retained.
116
q
2010 The Congress of Neurological Surgeons
Santarius et al
Clinical Neurosurgery
Volume 57, 2010
treated with either craniotomy or BHC. They found that the
recurrence rate and functional outcome were better in patients
treated with BHC than those who received craniotomy.
Although the size of the series is rather small and the study
falls short of today’s expected methodological rigor, numerous
prospective and retrospective case series that followed and
2 meta-analyses have confirmed the findings of Svien and
Gekety.
2,90
Nevertheless, many surgeons use minicraniotomies
as the method of choice for evacuation of CSDH, and good
results with the use of craniotomy, in terms of both recurrence
and functional outcome, have been reported by a number of
teams.
111,113-115
Craniotomy and BHC have not been compared
in an appropriately powered clinical trial. The results of the
study by Tanikawa et al
116
suggest that hematomas with
multilayer structure of hematoma membranes demonstrated
by T2*-weighted magnetic resonance imaging are more
TABLE 2. Predisposing Factors for the Development and Recurrence of Chronic Subdural Hematoma
a
Factor
Predisposing to Occurrence
(Positive or Negative Association)
Predisposing to Recurrence
(Positive or Negative Association)
Age
All articles
Positive
86,94
Male sex
All articles
Positive
94
History of head injury
All articles
History of falls
Positive
133,143,144
Epilepsy
Positive
133
Positive
145
Diabetes mellitus
Negative
145
Alcoholism
Positive
26,133,146
Positive
147,148
Anticoagulation/coagulopathies
Positive
133,68,146,147,149,150–154
Positive
26,143
Neutral
155,156
Antiplatelet agents
Positive
33,126,143,149,151,153,157
ACE inhibitors
Negative
53
Negative
53
Low-ICP states
Positive
33,158–162
High density on preoperative CT
Positive
163
Width of hematoma on preoperative CT
Positive
145
Midline shift . 5 mm on preoperative CT
Positive
164
Multiplicity of hematoma cavities on preoperative CT
Negative
145
Homogeneous type on preoperative CT
Negative
164
Homogeneous type on preoperative CT
Negative
165
Separated type on preoperative CT
Positive
56,164,165
Evidence of cerebral infarction on preoperative CT
Positive
86,166
Brain atrophy
Positive
48,159,167
Positive
166,168
Subdural hygroma
Positive
20,21,23,169
Poor brain expansion
NA
Positive
26,86,89,135,164
Thick subdural membrane
Positive
89
Preoperative irrigation
Positive
104,170
Postoperative irrigation
Negative
105
Subtemporal marsupialization
Negative
83
Placement of subdural drains
Negative
84,88,89,94,96–98
Placement of subgaleal/subperiosteal drains
Negative
87,95
Frontal position of drain
Negative
109,171
Postoperative bed rest
Negative1
40
Neutral1
39
Postoperative air on CT
110,86,94,148,163,164,168,170,172,173
High postoperative volume on CT
Positive
171
Higher GOS at discharge
Positive
163
High levels of b-trace protein in subdural fluid
Positive
28
High concentration of tPA in subdural fluid
Positive
42
a
ACE, angiotensin-converting enzyme; CT, computed tomography; GOS, Glasgow Outcome score; ICP, intracranial pressure; tPA, tissue plasminogen
activator. This table lists factors that have been reported in the literature as associated with or predictive of development or recurrence of CSDH. There was a great
variation in the quality of evidence for the role of individual factors. Whenever possible, we tried to preserve the original description of each factor. This resulted in
a degree of redundancy because some listed factors represent different aspects or merely different description of the same phenomenon (ie, brain atrophy, age,
width of hematoma, evidence of infarct on the CT, lack of preoperative or postoperative brain expansion, high postoperative volume on CT).
q
2010 The Congress of Neurological Surgeons
117
Clinical Neurosurgery
Volume 57, 2010
Chronic Subdural Haematoma-Review
effectively treated with craniotomy than BHC. Future studies
of imaging in the selection of the optimal surgical technique
will likely define the role of craniotomy in the management
of CSDH. In the meantime, most surgeons would agree with
the statement from Markwalder
33
in a 1981 review that
craniotomy should be considered in those instances in which
the subdural collection reaccumulates, there is solid hematoma,
or the brain fails to expand and obliterate the subdural space.
TDC
In a recent paper, Rughani et al
117
reviewed the literature
concerning TDC. The authors identified 16 articles published
in English.
104,118-132
Weigel et al
2
have found that although the
morbidity and mortality of TDC were similar to those of BHC,
the recurrence rate was significantly greater than that of either
BHC or craniotomy. The main advantage of TDC, however, is
the possibility of performing it at bedside, which may be a con-
sideration as the costs of operating theater time continue to rise.
Conservative Management
Our recent survey found that conservative management is
rarely practiced in the United Kingdom and the Republic of
Ireland.
93
Poorer outcome and prolonged hospital stay
associated with conservative management are the main reasons
for not pursuing this treatment option more often.
133-136
However, numerous cases of spontaneous resorption have
been published,
137,138
and Delgado-Lo´pez et al
67
reported
nonsurgical (dexamethasone-based) healing of up to two-thirds
of 101 carefully selected CSDHs. Because surgical treatment
brings about rapid improvement in patients’ clinical condition,
overall, operative management is the treatment of choice, and
conservative management tends to be reserved for patients who
either are asymptomatic or have a high perceived operative risk.
Adjuvant Treatment
Approximately 55% of surgeons in Canada and the
British Isles prescribe postoperative bed rest after the evacuation
of CSDH.
91,93
This lack of consensus is consistent with the
status of the available evidence. In a randomized trial, Nakajima
et al
139
prospectively divided 46 patients into 2 groups of 23
patients. One group was kept flat for 3 days, and the other was
allowed to sit up. The recurrence rates were 14.3% and 16%,
respectively, and the difference was not significant. Abouzari
et al
140
recently conducted a similar prospective randomized
study with a 3-month follow-up and greater statistical power (84
patients). The recurrence rate was 2.3% in the supine group and
19% in the sitting group. There were significant differences in
the incidence of atelectasis, pneumonia, bedsores, and deep
venous thrombosis between the groups. These data suggest that
there is a role for postoperative bed rest, but it is unclear whether
the same reduction in risk of recurrence could be obtained with
, 3 days of bed rest, as currently practiced by 93% of British
and 99% of Canadian neurosurgeons.
91,93
The potential role of corticosteroids and ACE inhibitors
in the management of CSDH is discussed in the Pathophys-
iology section.
SUMMARY
Surgical drainage is a relatively safe and effective
treatment for CSDH. Class II evidence exists for BHC being
the treatment of choice for an uncomplicated primary CSDH.
Together with previously published literature, our recent
randomized controlled trial provides Class I evidence for the
use of a drain with BHC. Craniotomy and TDC also play a role
in the management of CSDH, but more clinical research is
needed to refine their specific indications. Many other technical
variations have been described, but they have largely been
driven by tradition, hypotheses, personal or departmental
experience, or case series. A similar level of evidence exists
for nonsurgical management that, most would agree, is best
reserved for patients who either are asymptomatic or have
a high perceived operative risk. In addition to steroids, ACE
inhibitors may also play a role in the management of CSDH.
A one-for-all management strategy is clearly not
appropriate. Creating rational bases for the selection of an
ideal treatment strategy for an individual patient should, in our
opinion, be one of the targets in the process of improving the
management of patients with CSDH. This can be achieved
through better understanding of the nature of the condition
through systematic basic science research, ascertaining the
merits of different surgical techniques in well-designed and
rigorously executed clinical trials, using advances in imaging
techniques to classify CSDH (a subject not addressed here),
and training and ongoing refinement of clinical acumen and
surgical skills of individual surgeons.
Disclosure
Dr Hutchinson is supported by an Academy of Medical
Sciences/Health Foundation Senior Surgical Scientist Fellow-
ship. The authors have no personal financial or institutional
interest in any of the drugs, materials, or devices described in
this article.
TABLE 3. Summary of Results of the Cambridge Chronic
Subdural Haematoma Trial
88
Drain Group,
n (%)
Nondrain
Group, n (%)
P
Recurrence rate at 6 mo
10/108 (9.3)
26/107 (24)
.003
Mortality at 30 d
4/106 (3.7)
8/105 (7.6)
.191
Mortality at 6 mo
9/105 (8.6)
19/105 (18.1)
.042
Favorable modified Rankin
scale at discharge
81/97 (84)
64/95 (67)
.009
Favorable modified Rankin
scale at 6 mo
64/76 (84)
60/85 (71)
.040
118
q
2010 The Congress of Neurological Surgeons
Santarius et al
Clinical Neurosurgery
Volume 57, 2010
REFERENCES
1. Kinsella K, Velkoff VA. An Aging World: 2001. Washington, DC: US
Government Printing Office; 2001. US Census Bureau Series P95/01-1, 9.
2. Weigel R, Schmiedek P, Krauss JK. Outcome of contemporary surgery
for chronic subdural haematoma: evidence based review [comment].
J Neurol Neurosurg Psychiatr. 2003;74(7):937-943.
3. Frederickson RG. The subdural space interpreted as a cellular layer of
meninges. Anat Rec. 1991;230(1):38-51.
4. Haines DE. On the question of a subdural space. Anat Rec. 1991;230(1):
3-21.
5. Haines DE, Harkey HL, al Mefty O. The ‘‘subdural’’ space: a new look
at an outdated concept. Neurosurgery. 1993;32(1):111-120.
6. Sato S, Suzuki J. Ultrastructural observations of the capsule of chronic
subdural hematoma in various clinical stages. J Neurosurg. 1975;43(5):
569-578.
7. Orlin JR, Osen KK, Hovig T. Subdural compartment in pig:
a morphologic study with blood and horseradish peroxidase infused
subdurally. Anat Rec. 1991;230(1):22-37.
8. Gennarelli TA, Thibault LE. Biomechanics of acute subdural hematoma.
J Trauma. 1982;22:680-686.
9. Jozsa LG, Fothi E. Trephined skulls in Hungary [in Hungarian].
Orvostort Kozl. 2007;52(1-2):15-30.
10. Marino R Jr, Gonzales-Portillo M. Preconquest Peruvian neurosurgeons:
a study of Inca and pre-Columbian trephination and the art of medicine
in ancient Peru. Neurosurgery. 2000;47(4):940-950.
11. Piek J, Lidke G, Terberger T, von Smekal U, Gaab MR. Stone age skull
surgery in Mecklenburg-Vorpommern: a systematic study. Neurosurgery.
1999;45(1):147-151.
12. Stone JL, Miles ML. Skull trepanation among the early Indians of
Canada and the United States. Neurosurgery. 1990;26(6):1015-1019.
13. Velasco-Suarez M, Bautista MJ, Garcia OR, Weinstein PR. Archaeo-
logical origins of cranial surgery: trephination in Mexico. Neurosurgery.
1992;31(2):313-318.
14. Wepfer JJ. Observationes anatomicae ex cadaveribus eorum, quos
sustulit apoplexia cum exercitatione de eius loco affecto. Schaffhausen,
Switzerland: O.A. Waldkirch; 1675.
15. Virchow R. Das ha¨matom der dura mater. Verh Phys Med Ges
Wu¨rzburg. 1857;7:134-142.
16. Trotter W. Chronic subdural haemorrhage of traumatic origin, and its
relation to pachymeningitis haemorrhagica interna. Br J Neurosurg.
1914;2:271-291.
17. Yamashima T, Friede RL. Why do bridging veins rupture into the virtual
subdural space? J Neurol Neurosurg Psychiatr. 1984;47(2):121-127.
18. Markwalder TM, Reulen HJ. Influence of neomembranous organisation,
cortical expansion and subdural pressure on the post-operative course of
chronic subdural haematoma: an analysis of 201 cases. Acta Neurochir
(Wein). 1986;79(2-4):100-106.
19. Koizumi H, Fukamachi A, Wakao T, Tasaki T, Nagaseki Y, Yanai Y.
Traumatic subdural hygromas in adults: on the possibility of
development of chronic subdural hematoma [author’s translation].
Neurol Med Chir (Tokyo). 1981;21(4):397-406.
20. Lee KS. Natural history of chronic subdural haematoma. Brain Inj. 2004;
18(4):351-358.
21. Lee KS, Bae WK, Bae HG, Yun IG. The fate of traumatic subdural
hygroma in serial computed tomographic scans. J Korean Med Sci.
2000;15(5):560-568.
22. Lee KS, Bae WK, Park YT, Yun IG. The pathogenesis and fate of
traumatic subdural hygroma. Br J Neurosurg. 1994;8:551-558.
23. Lee KS, Bae WK, Yoon SM, Doh JW, Bae HG, Yun IG. Location of the
chronic subdural haematoma: role of the gravity and cranial morphology.
Brain Inj. 2001;15(5):47-52.
24. Murata K. Chronic subdural hematoma may be preceded by persistent
traumatic subdural effusion. Neurol Med Chir (Tokyo). 1993;33(10):691-696.
25. Park CK, Choi KH, Kim MC, Kang JK, Choi CR. Spontaneous
evolution of posttraumatic subdural hygroma into chronic subdural
haematoma. Acta Neurochir (Wein). 1994;127(1-2):41-47.
26. Stroobandt G, Fransen P, Thauvoy C, Menard E. Pathogenetic factors in
chronic subdural haematoma and causes of recurrence after drainage.
Acta Neurochir (Wein). 1995;137(1-2):6-14.
27. Yamada H, Watanabe T, Murata S, et al. Developmental process of
chronic subdural collections of fluid based on CT scan findings. Surg
Neurol. 1980;13(6):441-448.
28. Kristof RA, Grimm JM, Stoffel-Wagner B. Cerebrospinal fluid leakage
into the subdural space: possible influence on the pathogenesis and
recurrence frequency of chronic subdural hematoma and subdural
hygroma. J Neurosurg. 2008;108(2):275-280.
29. Friede RL, Schachenmayr W. The origin of subdural neomembranes, II:
fine structural of neomembranes. Am J Pathol. 1978;92(1):69-84.
30. Schachenmayr W, Friede RL. The origin of subdural neomembranes, I:
fine structure of the dura-arachnoid interface in man. Am J Pathol. 1975;
92(1):53-68.
31. Croce MA, Dent DL, Menke PG, et al. Acute subdural hematoma:
nonsurgical management of selected patients. J Trauma. 1994;36(6):
820-826.
32. Dolinskas CA, Zimmerman RA, Bilaniuk LT, Gennarelli TA. Computed
tomography of post-traumatic extracerebral hematomas: comparison to
pathophysiology and responses to therapy. J Trauma. 1979;19(3):
163-169.
33. Markwalder TM. Chronic subdural hematomas: a review. J Neurosurg.
1981;54:637-645.
34. Putnam TJ, Cuhing H. Chronic subdural haematoma: its pathology, its
relation to pachymeningitis haemorrhagica interna and its surgical
treatment. Arch Surg. 1925;11:329-339.
35. Ito H, Yamamoto S, Saito K, Ikeda K, Hisada K. Quantitative estimation
of hemorrhage in chronic subdural hematoma using the
51
Cr erythrocyte
labeling method. J Neurosurg. 1987;66(6):862-864.
36. Aikawa H, Suzuki K. Experimental chronic subdural hematoma in mice:
gross morphology and light microscopic observations. J Neurosurg.
1987;67(5):710-716.
37. Yamashima T, Yamamoto S, Friede RL. The role of endothelial gap
Dostları ilə paylaş: |